Advertisement

Relation of Morbid Obesity and Female Gender to Risk of Procedural Complications in Patients Undergoing Atrial Fibrillation Ablation

Published:November 19, 2012DOI:https://doi.org/10.1016/j.amjcard.2012.10.013
      Obese patients with atrial fibrillation (AF) are frequently treated with AF ablation. We sought to examine whether a body mass index (BMI) threshold exists beyond which the odds of experiencing a complication from AF ablation increases. All patients enrolled in the Vanderbilt AF Registry who underwent catheter-based AF ablation from May 1999 to February 2012 were included. Major complications were recorded. Morbid obesity was defined as a BMI >40 kg/m2 and examined in multivariable analysis. A total of 35 complications (6.8%) occurred in 512 ablations. Morbidly obese patients experienced a greater rate of complications (6 of 42, 14.3%) than the nonmorbidly obese (29 of 470, 6.2%; p = 0.046). Using a discrete BMI cutoff, the odds of complications increased 3.1-fold in those with morbid obesity (odds ratio [OR] 3.1, 95% confidence interval [CI] 1.1 to 8.4, p = 0.03) and 2.1-fold for female gender (OR 2.1, 95% CI 1.04 to 4.38, p = 0.04). With BMI as a continuous variable, the odds of complications increased by 5% per 1 unit increase in BMI (OR 1.05, 95% CI 1.0 to 1.11, p = 0.05), and the increase for female gender was 2.2-fold (OR 2.2, 95% CI 1.1 to 4.6, p = 0.03). In conclusion, morbid obesity represents a BMI threshold above which the odds of complications with AF ablation increase significantly. The increase in complications appears to be driven primarily by events in women, suggesting that morbidly obese women are a special population when considering AF ablation.
      To read this article in full you will need to make a payment

      References

        • Shah R.U.
        • Freeman J.V.
        • Shilane D.
        • Wang P.J.
        • Go A.S.
        • Hlatky M.A.
        Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation.
        J Am Coll Cardiol. 2012; 59: 143-149
        • Baman T.S.
        • Jongnarangsin K.
        • Chugh A.
        • Suwanagool A.
        • Guiot A.
        • Madenci A.
        • Walsh S.
        • Ilg K.J.
        • Gupta S.K.
        • Latchamsetty R.
        • Bagwe S.
        • Myles J.D.
        • Crawford T.
        • Good E.
        • Bogun F.
        • Pelosi Jr., F.
        • Morady F.
        • Oral H.
        Prevalence and predictors of complications of radiofrequency catheter ablation for atrial fibrillation.
        J Cardiovasc Electr. 2011; 22: 626-631
        • Spragg D.D.
        • Dalal D.
        • Cheema A.
        • Scherr D.
        • Chilukuri K.
        • Cheng A.
        • Henrikson C.A.
        • Marine J.E.
        • Berger R.D.
        • Dong J.
        • Calkins H.
        Complications of catheter ablation for atrial fibrillation: incidence and predictors.
        J Cardiovasc Electr. 2008; 19: 627-631
        • Bertaglia E.
        • Zoppo F.
        • Tondo C.
        • Colella A.
        • Mantovan R.
        • Senatore G.
        • Bottoni N.
        • Carreras G.
        • Coro L.
        • Turco P.
        • Mantica M.
        • Stabile G.
        Early complications of pulmonary vein catheter ablation for atrial fibrillation: A multicenter prospective registry on procedural safety.
        Heart Rhythm. 2007; 4: 1265-1271
        • Hoyt H.
        • Bhonsale A.
        • Chilukuri K.
        • Alhumaid F.
        • Needleman M.
        • Edwards D.
        • Govil A.
        • Nazarian S.
        • Cheng A.
        • Henrikson C.A.
        • Sinha S.
        • Marine J.E.
        • Berger R.
        • Calkins H.
        • Spragg D.D.
        Complications arising from catheter ablation of atrial fibrillation: temporal trends and predictors.
        Heart Rhythm. 2011; 8: 1869-1874
        • Cha Y.M.
        • Friedman P.A.
        • Asirvatham S.J.
        • Shen W.K.
        • Munger T.M.
        • Rea R.F.
        • Brady P.A.
        • Jahangir A.
        • Monahan K.H.
        • Hodge D.O.
        • Meverden R.A.
        • Gersh B.J.
        • Hammill S.C.
        • Packer D.L.
        Catheter ablation for atrial fibrillation in patients with obesity.
        Circulation. 2008; 117: 2583-2590
      1. Letsas KP, Siklody CH, Korantzopoulos P, Weber R, Burkle G, Mihas CC, Kalusche D, Arentz T. The impact of body mass index on the efficacy and safety of catheter ablation of atrial fibrillation. Int J Cardiol Epub 2011 Jul 2.

        • Byrne J.
        • Spence M.S.
        • Fretz E.
        • Mildenberger R.
        • Chase A.
        • Berry B.
        • Pi D.
        • Janssen C.
        • Klinke P.
        • Hilton D.
        Body mass index, periprocedural bleeding, and outcome following percutaneous coronary intervention (from the British Columbia Cardiac Registry).
        Am J Cardiol. 2009; 103: 507-511
        • Ellis S.G.
        • Elliott J.
        • Horrigan M.
        • Raymond R.E.
        • Howell G.
        Low-normal or excessive body mass index: newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention.
        Am J Cardiol. 1996; 78: 642-646
        • Gruberg L.
        • Weissman N.J.
        • Waksman R.
        • Fuchs S.
        • Deible R.
        • Pinnow E.E.
        • Ahmed L.M.
        • Kent K.M.
        • Pichard A.D.
        • Suddath W.O.
        • Satler L.F.
        • Lindsay Jr., J.
        The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox?.
        J Am Coll Cardiol. 2002; 39: 578-584
        • Gurm H.S.
        • Brennan D.M.
        • Booth J.
        • Tcheng J.E.
        • Lincoff A.M.
        • Topol E.J.
        Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox).
        Am J Cardiol. 2002; 90: 42-45
        • Minutello R.M.
        • Chou E.T.
        • Hong M.K.
        • Bergman G.
        • Parikh M.
        • Iacovone F.
        • Wong S.C.
        Impact of body mass index on in-hospital outcomes following percutaneous coronary intervention (report from the New York State Angioplasty Registry).
        Am J Cardiol. 2004; 93: 1229-1232
        • Darbar D.
        • Motsinger A.A.
        • Ritchie M.D.
        • Gainer J.V.
        • Roden D.M.
        Polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation.
        Heart Rhythm. 2007; 4: 743-749
        • Harris P.A.
        • Taylor R.
        • Thielke R.
        • Payne J.
        • Gonzalez N.
        • Conde J.G.
        Research electronic data capture (REDCAP)—a metadata-driven methodology and workflow process for providing translational research informatics support.
        J Biomed Inform. 2009; 42: 377-381
        • Calkins H.
        • Brugada J.
        • Packer D.L.
        • Cappato R.
        • Chen S.A.
        • Crijns H.J.
        • Damiano Jr., R.J.
        • Davies D.W.
        • Haines D.E.
        • Haissaguerre M.
        • Iesaka Y.
        • Jackman W.
        • Jais P.
        • Kottkamp H.
        • Kuck K.H.
        • Lindsay B.D.
        • Marchlinski F.E.
        • McCarthy P.M.
        • Mont J.L.
        • Morady F.
        • Nademanee K.
        • Natale A.
        • Pappone C.
        • Prystowsky E.
        • Raviele A.
        • Ruskin J.N.
        • Shemin R.J.
        HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up—a report of the Heart Rhythm Society (HRS) task force on catheter and surgical ablation of atrial fibrillation.
        Heart Rhythm. 2007; 4: 816-861
        • Gurm H.S.
        • Whitlow P.L.
        • Kip K.E.
        The impact of body mass index on short- and long-term outcomes inpatients undergoing coronary revascularization: insights from the bypass angioplasty revascularization investigation (BARI).
        J Am Coll Cardiol. 2002; 39: 834-840
        • Powell B.D.
        • Lennon R.J.
        • Lerman A.
        • Bell M.R.
        • Berger P.B.
        • Higano S.T.
        • Holmes Jr., D.R.
        • Rihal C.S.
        Association of body mass index with outcome after percutaneous coronary intervention.
        Am J Cardiol. 2003; 91: 472-476
        • Patel D.
        • Mohanty P.
        • Di Biase L.
        • Sanchez J.E.
        • Shaheen M.H.
        • Burkhardt J.D.
        • Bassouni M.
        • Cummings J.
        • Wang Y.
        • Lewis W.R.
        • Diaz A.
        • Horton R.P.
        • Beheiry S.
        • Hongo R.
        • Gallinghouse G.J.
        • Zagrodzky J.D.
        • Bailey S.M.
        • Al-Ahmad A.
        • Wang P.
        • Schweikert R.A.
        • Natale A.
        Outcomes and complications of catheter ablation for atrial fibrillation in females.
        Heart Rhythm. 2010; 7: 167-172
        • Kawamura A.
        • Piemonte T.C.
        • Nesto R.W.
        • Bilazarian S.D.
        • Riskalla N.S.
        • Chauhan M.S.
        Impact of gender on in-hospital outcomes following contemporary percutaneous intervention for peripheral arterial disease.
        J Invasive Cardiol. 2005; 17: 433-436
        • Farouque H.M.
        • Tremmel J.A.
        • Raissi Shabari F.
        • Aggarwal M.
        • Fearon W.F.
        • Ng M.K.
        • Rezaee M.
        • Yeung A.C.
        • Lee D.P.
        Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices.
        J Am Coll Cardiol. 2005; 45: 363-368
        • Siddharth P.
        • Smith N.L.
        • Mason R.A.
        • Giron F.
        Variational anatomy of the deep femoral artery.
        Anat Rec. 1985; 212: 206-209
        • Hughes P.
        • Scott C.
        • Bodenham A.
        Ultrasonography of the femoral vessels in the groin: implications for vascular access.
        Anaesthesia. 2000; 55: 1198-1202